banner
FLT3 inhibitor TG101209, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ187

FLT3 inhibitor TG101209, Purity ≥98%

Synonym: 936091-14-4; TG101209; TG-101209; TG 101209; N-tert-Butyl-3-(5-methyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide; N-tert-Butyl-3-[[5-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide; FLT3 inhibitor

  • MDL: MFCD15528085
  • CAS Number: 936091-14-4
  • Compound CID: 16722832
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TG101209, soluble in DMSO and insoluble in ethanol and water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FLT3. It targets JAK2, RET, FLT3, and JAK3.
Molecular Weight
509.67
Molecular Formula
C26H35N7O2S
Targets
JAK2: 6 nM; RET: 17 nM; FLT3: 25 nM; JAK3: 169 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 94 mg/mL (184.42 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
TG101209 can be used to explore the inhibition of JAK2 and its potential therapeutic applications in myeloproliferative disorders.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0